NVST (Envista Holdings) EBIT: $270 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NVST Envista Holdings Corp NVST
79 GF Score
Price $27.99
GF Value $23.94
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Envista Holdings EBIT?

Envista Holdings NVST -2.24% 79 EBIT is $270 Mil as of Jun. 2026. GuruFocus rates NVST with a GF Score™ of 79/100 and a GF Value™ of $23.94 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Envista Holdings's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2026 was $83 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2026 was $270 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Envista Holdings's annualized ROC % for the quarter that ended in Jun. 2026 was 5.47%. Envista Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 64.16%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Envista Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 5.32%.


Envista Holdings  (NYSE:NVST) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Envista Holdings's annualized ROC % for the quarter that ended in Jun. 2026 is calculated as:

ROC % (Q: Jun. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2026 ) + Invested Capital (Q: Jun. 2026 ))/ count )
=321.2 * ( 1 - 27.82% )/( (4257.7 + 4221.4)/ 2 )
=231.84216/4239.55
=5.47 %

where

Note: The Operating Income data used here is four times the quarterly (Jun. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Envista Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2026  Q: Jun. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=332.4/( ( (442.3 + max(88.4, 0)) + (441.9 + max(63.6, 0)) )/ 2 )
=332.4/( ( 530.7 + 505.5 )/ 2 )
=332.4/518.1
=64.16 %

where Working Capital is:

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(436.6 + 300.3 + 99.4) - (237.5 + 188.1 + 322.3)
=88.4

Working Capital(Q: Jun. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(436.9 + 290.9 + 104.6) - (250.1 + 191.7 + 327)
=63.6

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Envista Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2026 )
=269.5/5061.152
=5.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Envista Holdings EBIT Related Terms


Envista Holdings EBIT Historical Data

* Premium members only.

The historical data trend for Envista Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Envista Holdings EBIT Chart

Envista Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 308.60 322.30 8.50 -1,038.30 213.80

Envista Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.70 58.90 67.90 59.60 83.10

NVST vs MMSI, ICUI, MMED: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Envista Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Envista Holdings EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Envista Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Envista Holdings's EV-to-EBIT falls into.


NVST
79GF Score
Envista Holdings Corp NVST
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Envista Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $270 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $270 Mil mean?
Envista Holdings (NVST) has a EBIT of $270 Mil as of Jun. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Envista Holdings.
Is Envista Holdings' EBIT too high?
Envista Holdings' current EBIT is $270 Mil. Overall, Envista Holdings has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Envista Holdings' EBIT compare to MMSI and ICUI?
Envista Holdings' EBIT of $270 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Envista Holdings. Envista Holdings's current EBIT is $270 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envista Holdings stock overvalued right now?
Based on GuruFocus' analysis, Envista Holdings (NVST) is currently considered Modestly Overvalued. The stock's GF Value™ is $23.94, compared to a current price of $27.99 — trading 16.9% above its estimated fair value. The current EBIT is $270 Mil. Envista Holdings' overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Envista Holdings (NVST), the current EBIT is $270 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Envista Holdings (NVST) Overvalued in 2026?

Based on GuruFocus' analysis, Envista Holdings stock appears to be overvalued. The current stock price of $27.99 is trading 16.9% above its estimated GF Value™ of $23.94. GuruFocus considers Envista Holdings to be Modestly Overvalued.

Key valuation signals for NVST:

  • EBIT: $270 Mil
  • GF Value™: $23.94 vs. price of $27.99 (16.9% above fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the NVST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Envista Holdings Business Description

Other Exchanges 0HV:Germany
Address 200 S. Kraemer Boulevard, Building E, Brea, CA, USA, 92821-6208
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
79GF Score

Get the complete analysis for NVST

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$27.99
Price
$23.94
GF Value